Curiox Biosystems Co., Ltd (KOSDAQ: 445680)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,350
+330 (1.74%)
Oct 10, 2024, 3:00 PM KST

Curiox Biosystems Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
358,289403,531---
Enterprise Value
346,041383,796---
Last Close Price
22300.0025150.00---
PE Ratio
--35.79---
PS Ratio
61.6559.45---
PB Ratio
7.347.63---
P/FCF Ratio
-43.10-48.18---
P/OCF Ratio
-43.17-49.43---
EV/Sales Ratio
60.7456.54---
EV/EBITDA Ratio
-39.64-44.60---
EV/EBIT Ratio
-32.73-36.35---
EV/FCF Ratio
-36.48-45.82---
Debt / Equity Ratio
0.020.020.011.400.46
Debt / FCF Ratio
-0.09-0.12-0.04-5.65-4.27
Asset Turnover
-0.130.140.11-
Inventory Turnover
-1.311.071.72-
Quick Ratio
6.697.263.750.660.72
Current Ratio
7.677.954.920.710.78
Return on Equity (ROE)
--20.76%-35.07%-60.04%-
Return on Assets (ROA)
--12.40%-13.67%-10.73%-
Return on Capital (ROIC)
--13.45%-14.81%-11.45%-
Earnings Yield
-3.10%-2.49%---
FCF Yield
-2.65%-2.08%---
Buyback Yield / Dilution
-80.11%-101.31%-8.91%--
Total Shareholder Return
-80.11%-101.31%-8.91%--
Source: S&P Capital IQ. Standard template. Financial Sources.